STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-08-23
Here’s whether Gilead Sciences Inc (GILD) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.68% over 10 days); strong 1-year return of +25.8%; 3-month momentum positive (+8.8%). Concerns: RSI 73 — overbought, elevated pullback risk. Currently 7.1% off its 52-week high. Score: +5/7.
GILD is in a confirmed uptrend, trading above both its 50-day ($131.90) and 200-day ($133.06) moving averages. With an RSI of 73.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +25.8% compares to +20.5% for SPY (beat the market by 5.3%).
$10,000 invested 1 year ago→ $12,581 today
vs. S&P 500 (SPY) — same period beat market by 5.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($133.06)
✓Above 50-day MA ($131.90)
!RSI(14) neutral zone (30–70) — currently 73.1
✓Positive return (+25.8%)
✓Within 10% of period high (−7.1%)
Period Range $146.12
$108.46$157.29
RSI (14) 73.1
0 · OversoldOverbought · 100
Key Metrics
Price$146.12
Period Return+25.8%
Period High$157.29
Period Low$108.46
Drawdown−7.1%
MA-50$131.90
MA-200$133.06
RSI (14)73.1
Avg Volume (30d)6.4M
vs. SPYbeat by 5.3%
Return Rank#371 of 999
Trend Signals
Price is above the 200-day moving average ($133.06)
Price is above the 50-day moving average ($131.90)